APA (7th ed.) Citation

R, J., N, S., X, S., R, A., & AG, L. (2017). SR-B1-targeted nanodelivery of anti-cancer agents: A promising new approach to treat triple-negative breast cancer. Dove Medical Press.

Chicago Style (17th ed.) Citation

R, Johnson, Sabnis N, Sun X, Ahluwalia R, and Lacko AG. SR-B1-targeted Nanodelivery of Anti-cancer Agents: A Promising New Approach to Treat Triple-negative Breast Cancer. Dove Medical Press, 2017.

MLA (8th ed.) Citation

R, Johnson, et al. SR-B1-targeted Nanodelivery of Anti-cancer Agents: A Promising New Approach to Treat Triple-negative Breast Cancer. Dove Medical Press, 2017.